Your browser doesn't support javascript.
loading
Pannexin 1 Channels as a Therapeutic Target: Structure, Inhibition, and Outlook.
Navis, Kathleen E; Fan, Churmy Y; Trang, Tuan; Thompson, Roger J; Derksen, Darren J.
Afiliação
  • Navis KE; Department of Chemistry, University of Calgary, Calgary, Alberta T2N 1N4, Canada.
  • Fan CY; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
  • Trang T; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
  • Thompson RJ; Department of Cell Biology and Anatomy, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
  • Derksen DJ; Department of Chemistry, University of Calgary, Calgary, Alberta T2N 1N4, Canada.
ACS Chem Neurosci ; 11(15): 2163-2172, 2020 08 05.
Article em En | MEDLINE | ID: mdl-32639715
ABSTRACT
Pannexin 1 (Panx1) channels are transmembrane proteins that release adenosine triphosphate and play an important role in intercellular communication. They are widely expressed in somatic and nervous system tissues, and their activity has been associated with many pathologies such as stroke, epilepsy, inflammation, and chronic pain. While there are a variety of small molecules known to inhibit Panx1, currently little is known about the mechanism of channel inhibition, and there is a dearth of sufficiently potent and selective drugs targeting Panx1. Herein we provide a review of the current literature on Panx1 structural biology and known pharmacological agents that will help provide a basis for rational development of Panx1 chemical modulators.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Conexinas / Epilepsia Limite: Humans Idioma: En Revista: ACS Chem Neurosci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Conexinas / Epilepsia Limite: Humans Idioma: En Revista: ACS Chem Neurosci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá